Skip Header

1 - 25 of 391 results for uniprot:Q9JLN9 in Computationally mapped citations

Page of 16 | Next »

to top of page·  

Results Customize

Akt maintains cell size and survival by increasing mTOR-dependent nutrient uptake.

Edinger A.L., Thompson C.B.

Mol. Biol. Cell 13:2276-2288(2002) GeneRIF 56717 · Mapped (6)
These results suggest that growth factors control cellular growth and survival by regulating cellular access to extracellular nutrients in part by modulating the activity of Akt and mTOR GeneRIF 56717

BCR/ABL induces expression of vascular endothelial growth factor and its transcriptional activator, hypoxia inducible factor-1alpha, through a pathway involving phosphoinositide 3-kinase and the mammalian target of rapamycin.

Mayerhofer M., Valent P., Sperr W.R., Griffin J.D., Sillaber C.

Blood 100:3767-3775(2002) GeneRIF 56717 · Mapped (11)
BCR/ABL induces expression of VEGF and its transcriptional activator HIF1A through a pathway involving phosphoinositide 3-kinase and the mammalian target of rapamycin (FRAP) in BaF3 cells. GeneRIF 56717

TSC2 regulates VEGF through mTOR-dependent and -independent pathways.

Brugarolas J.B., Vazquez F., Reddy A., Sellers W.R., Kaelin W.G. Jr.

Cancer Cell 4:147-158(2003) GeneRIF 56717 · Mapped (15)
mTOR-independent link between TSC2 loss and VEGF GeneRIF 56717

mTor is required for hypertrophy of Pten-deficient neuronal soma in vivo.

Kwon C.H., Zhu X., Zhang J., Baker S.J.

Proc. Natl. Acad. Sci. U.S.A. 100:12923-12928(2003) GeneRIF 56717 · Mapped (7)
mTor is required for hypertrophy of Pten-deficient neuronal soma in vivo. GeneRIF 56717

Loss of Tsc1/Tsc2 activates mTOR and disrupts PI3K-Akt signaling through downregulation of PDGFR.

Zhang H., Cicchetti G., Onda H., Koon H.B., Asrican K., Bajraszewski N., Vazquez F., Carpenter C.L., Kwiatkowski D.J.

J. Clin. Invest. 112:1223-1233(2003) GeneRIF 56717 · Mapped (29)
Loss of Tsc1/Tsc2 activates mTOR and disrupts PI3K-Akt signaling through downregulation of PDGFR. GeneRIF 56717

MAP kinases and mTOR mediate insulin-induced phosphorylation of insulin receptor substrate-1 on serine residues 307, 612 and 632.

Gual P., Gremeaux T., Gonzalez T., Le Marchand-Brustel Y., Tanti J.F.

Diabetologia 46:1532-1542(2003) GeneRIF 56717 MGI 1928394 · Mapped (11)
Insulin-induced phosphorylation of Serine(307) was dependent on the activation of a PI 3-kinase/mTOR pathway GeneRIF 56717

mTOR-dependent regulation of ribosomal gene transcription requires S6K1 and is mediated by phosphorylation of the carboxy-terminal activation domain of the nucleolar transcription factor UBF.

Hannan K.M., Brandenburger Y., Jenkins A., Sharkey K., Cavanaugh A., Rothblum L., Moss T., Poortinga G., McArthur G.A., Pearson R.B. et al.

Mol. Cell. Biol. 23:8862-8877(2003) GeneRIF 56717 · Mapped (10)
mTOR plays a critical role in the regulation of ribosome biogenesis via a mechanism that requires S6K1 activation and phosphorylation of UBF. GeneRIF 56717

Frap, FKBP12 rapamycin-associated protein, is a candidate gene for the plasmacytoma resistance locus Pctr2 and can act as a tumor suppressor gene.

Bliskovsky V., Ramsay E.S., Scott J., DuBois W., Shi W., Zhang S., Qian X., Lowy D.R., Mock B.A.

Proc. Natl. Acad. Sci. U.S.A. 100:14982-14987(2003) GeneRIF 56717 MGI 1928394 · Mapped (7)
Frap is a candidate gene for the plasmacytoma resistance locus Pctr2 and can act as a tumor suppressor gene GeneRIF 56717

mTOR inhibition reverses Akt-dependent prostate intraepithelial neoplasia through regulation of apoptotic and HIF-1-dependent pathways.

Majumder P.K., Febbo P.G., Bikoff R., Berger R., Xue Q., McMahon L.M., Manola J., Brugarolas J., McDonnell T.J., Golub T.R. et al.

Nat. Med. 10:594-601(2004) GeneRIF 56717 · Mapped (11)
Data suggest that the expansion of AKT-driven prostate epithelial cells requires mTOR-dependent survival signaling and activation of hypoxia inducible factor (HIF)-1 alpha. GeneRIF 56717

Activation of the phosphoinositide 3-kinase-Akt-mammalian target of rapamycin signaling pathway is required for metabotropic glutamate receptor-dependent long-term depression.

Hou L., Klann E.

J. Neurosci. 24:6352-6361(2004) GeneRIF 56717 · Mapped (17)
Activation of the PI3K-Akt-mTOR signaling cascade is required for mGluR-mediated long-term depression in the hippocampus. GeneRIF 56717

mTOR is essential for growth and proliferation in early mouse embryos and embryonic stem cells.

Murakami M., Ichisaka T., Maeda M., Oshiro N., Hara K., Edenhofer F., Kiyama H., Yonezawa K., Yamanaka S.

Mol. Cell. Biol. 24:6710-6718(2004) GeneRIF 56717 MGI 1928394 · Mapped (3)
mTOR controls both cell size and proliferation in early mouse embryos and embryonic stem cells GeneRIF 56717

Insulin-like growth factor-1 (IGF-1) inversely regulates atrophy-induced genes via the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin (PI3K/Akt/mTOR) pathway.

Latres E., Amini A.R., Amini A.A., Griffiths J., Martin F.J., Wei Y., Lin H.C., Yancopoulos G.D., Glass D.J.

J. Biol. Chem. 280:2737-2744(2005) GeneRIF 56717 · Mapped (8)
both the Akt/FOXO and the Akt/mTOR pathways are required for the transcriptional changes induced by IGF-1 GeneRIF 56717

Activation of the mammalian target of rapamycin pathway acutely inhibits insulin signaling to Akt and glucose transport in 3T3-L1 and human adipocytes.

Tremblay F., Gagnon A., Veilleux A., Sorisky A., Marette A.

Endocrinology 146:1328-1337(2005) GeneRIF 56717 · Mapped (8)
the mTOR pathway is an important modulator of the signals involved in the acute regulation of insulin-stimulated glucose transport in 3T3-L1 and human adipocytes GeneRIF 56717

The stress-inducted proteins RTP801 and RTP801L are negative regulators of the mammalian target of rapamycin pathway.

Corradetti M.N., Inoki K., Guan K.-L.

J. Biol. Chem. 280:9769-9772(2005) GeneRIF 56717 · UniProtKB (4) · Mapped (15)
RTP801 and RTP801L work downstream of AKT and upstream of TSC2 to inhibit mTOR functions GeneRIF 56717

Atrophy of S6K1(-/-) skeletal muscle cells reveals distinct mTOR effectors for cell cycle and size control.

Ohanna M., Sobering A.K., Lapointe T., Lorenzo L., Praud C., Petroulakis E., Sonenberg N., Kelly P.A., Sotiropoulos A., Pende M.

Nat. Cell Biol. 7:286-294(2005) GeneRIF 56717 · Mapped (25)
S6 kinase 1 is essential for the control of muscle cytoplasmic volume by Akt and mTOR GeneRIF 56717

The tuberous sclerosis protein TSC2 is not required for the regulation of the mammalian target of rapamycin by amino acids and certain cellular stresses.

Smith E.M., Finn S.G., Tee A.R., Browne G.J., Proud C.G.

J. Biol. Chem. 280:18717-18727(2005) GeneRIF 56717 · Mapped (15)
TSC2 is not required for the regulation of mTOR by amino acids and certain cellular stresses GeneRIF 56717

Role of mammalian target of rapamycin signaling in compensatory renal hypertrophy.

Chen J.K., Chen J., Neilson E.G., Harris R.C.

J. Am. Soc. Nephrol. 16:1384-1391(2005) GeneRIF 56717 · Mapped (3)
activation of the mTOR signaling pathway in the remaining kidney after unilateral nephrectomy plays an essential role in modulating RNA and protein synthesis during development of compensatory renal hypertrophy GeneRIF 56717

Negative regulation of melanogenesis by phospholipase D1 through mTOR/p70 S6 kinase 1 signaling in mouse B16 melanoma cells.

Ohguchi K., Banno Y., Nakagawa Y., Akao Y., Nozawa Y.

J. Cell. Physiol. 205:444-451(2005) GeneRIF 56717 · Mapped (12)
Phospholipase D1 exerts a negative regulatory role in the melanogenic process through mTOR/S6K1 signaling. GeneRIF 56717

Skeletal myocyte hypertrophy requires mTOR kinase activity and S6K1.

Park I.H., Erbay E., Nuzzi P., Chen J.

Exp. Cell Res. 309:211-219(2005) GeneRIF 56717 MGI 1928394 · Mapped (9)
the requirement of mTOR and its downstream effector S6K1 in the regulation of myotube hypertrophy GeneRIF 56717

mTOR promotes survival and astrocytic characteristics induced by Pten/AKT signaling in glioblastoma.

Hu X., Pandolfi P.P., Li Y., Koutcher J.A., Rosenblum M., Holland E.C.

Neoplasia 7:356-368(2005) GeneRIF 56717 · Mapped (14)
mTOR promotes survival and astrocytic characteristics induced by Pten/AKT signaling in glioblastoma GeneRIF 56717

Akt activates the mammalian target of rapamycin by regulating cellular ATP level and AMPK activity.

Hahn-Windgassen A., Nogueira V., Chen C.C., Skeen J.E., Sonenberg N., Hay N.

J. Biol. Chem. 280:32081-32089(2005) GeneRIF 56717 · Mapped (16)
activation of mTOR by Akt-mediated cellular energy and inhibition of AMPK is the predominant pathway by which Akt activates mTOR in vivo GeneRIF 56717

Roles of mTOR and JNK in serine phosphorylation, translocation, and degradation of IRS-1.

Hiratani K., Haruta T., Tani A., Kawahara J., Usui I., Kobayashi M.

Biochem. Biophys. Res. Commun. 335:836-842(2005) GeneRIF 56717 · Mapped (12)
mTOR and JNK play roles in phosphorylating IRS-1 serine residues and that insulin and anisomycin are different in terms of the relationship of activation between mTOR and JNK and the effects on IRS-1 localization and stability GeneRIF 56717

Glutamatergic regulation of the p70S6 kinase in primary mouse neurons.

Lenz G., Avruch J.

J. Biol. Chem. 280:38121-38124(2005) GeneRIF 56717 · Mapped (9)
the mTOR-S6K pathway in neurons is activated by glutamatergic stimulation in a calcium/calmodulin-dependent fashion through a calcium pool controlled by postsynaptic voltage-dependent calcium channels GeneRIF 56717

Hypoxia-inducible factor determines sensitivity to inhibitors of mTOR in kidney cancer.

Thomas G.V., Tran C., Mellinghoff I.K., Welsbie D.S., Chan E., Fueger B., Czernin J., Sawyers C.L.

Nat. Med. 12:122-127(2006) GeneRIF 56717 · Mapped (20)
HIF1a has a role in determining sensitivity to inhibitors of mTOR in kidney cancer GeneRIF 56717

Inhibition of mTOR signaling with rapamycin attenuates renal hypertrophy in the early diabetic mice.

Sakaguchi M., Isono M., Isshiki K., Sugimoto T., Koya D., Kashiwagi A.

Biochem. Biophys. Res. Commun. 340:296-301(2006) GeneRIF 56717 · Mapped (3)
Our findings suggest that activation of mTOR signaling causes renal hypertrophy at the early stage of diabetes. GeneRIF 56717

to top of page·

Page of 16 | Next »